Advertisement

Celiac Disease and Hypothyroidism

      Abstract

      Background

      Celiac disease is more common in patients with hypothyroidism. Malabsorption of levothyroxine has not been studied in this population. We sought to determine if levothyroxine dosing was influenced by the presence and treatment of celiac disease.

      Methods

      This retrospective study was conducted at an academic medical center. Cases had hypothyroidism and celiac disease. Controls had hypothyroidism alone and were selected randomly through the endocrinology clinic records. Celiac disease was defined as representative pathology with positive serology. Age, sex, height, weight, body mass index, creatinine, and medical comorbidity were assessed for cases and controls. The levothyroxine dose and weight-based levothyroxine dose necessary to maintain a euthyroid state was evaluated for controls, and before and after celiac disease therapy for cases.

      Results

      Celiac disease was identified in 152 patients, and 22 patients had concomitant hypothyroidism (14.5%). Seven cases met inclusion criteria. Overall, 200 control patients were identified. The mean celiac disease pretreatment levothyroxine dose and weight-based levothyroxine dose needed to maintain a euthyroid state were higher in cases than in controls (154 μg vs 106 μg, P=.007, and 2.6 μg/kg vs 1.3 μg/kg, P <.001). Doses decreased significantly after treatment of celiac disease (154 μg vs 111 μg, P=.03; and 2.64 μg/kg vs 1.89 μg/kg, P=.04). All cases required at least 125 μg of levothyroxine initially to maintain a euthyroid state.

      Conclusions

      Levothyroxine malabsorption likely occurs with hypothyroidism and untreated celiac disease. Absorption may improve after celiac disease treatment. Screening for celiac disease in patients with hypothyroidism requiring elevated levothyroxine doses warrants further investigation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fasano A.
        • Berti I.
        • Gerarduzzi T.
        • et al.
        Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.
        Arch Intern Med. 2003; 163: 286-292
        • Rostom A.
        • Murray J.A.
        • Kagnoff M.F.
        American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease.
        Gastroenterology. 2006; 131: 1981-2002
        • Welling P.G.
        • Tse F.L.S.
        Factors contributing to variability in drug pharmacokinetics.
        J Clin Hosp Parm. 1984; 9: 163-179
        • Parsons R.L.
        • Hossack G.
        • Paddock G.
        The absorption of antibiotics in adult patients with celiac disease.
        J Antimicrob Chemother. 1975; 1: 39-50
        • Parsons R.L.
        • Kaye C.M.
        • Raymond K.
        Pharmacokinetics of salicylate and indomethacin in celiac disease.
        Eur J Clin Pharmacol. 1977; 11: 473-477
        • Neuhausen S.L.
        • Steele L.
        • Ryan S.
        • et al.
        Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives.
        J Autoimmun. 2008; 31: 160-165
        • Counsell C.E.
        • Taha A.
        • Ruddell W.S.
        Celiac disease and autoimmune thyroid disease.
        Gut. 1994; 35: 844-846
        • Meloni A.
        • Mandas C.
        • Jores R.D.
        • et al.
        Prevalence of autoimmune thyroiditis with celiac disease and effect of gluten withdrawal.
        J Pediatr. 2009; 155: 51-55
        • Ch'ng C.L.
        • Jones M.K.
        • Kingham J.G.C.
        • et al.
        Celiac disease and autoimmune thyroid disease.
        Clin Med Res. 2007; 5: 184-192
        • Volta U.
        • Ravaglia G.
        • Granito A.
        • et al.
        Coeliac disease in patients with autoimmune thyroiditis.
        Digestion. 2001; 64: 61-65
        • Mainardi E.
        • Montanelli A.
        • Dotti M.
        • et al.
        Thyroid-related antibodies and celiac disease: a role for a gluten-free diet?.
        J Clin Gastroenterol. 2002; 35: 245-248
        • Boelaert K.
        • Newby P.R.
        • Simmonds M.J.
        • et al.
        Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.
        Am J Med. 2010; 123: 183.e1-183.e9
        • Liwanpo L.
        • Hershman J.M.
        Conditions and drugs interfering with thyroxine absorption.
        Best Pract Res Clin Endocrinol Metab. 2009; 23: 781-792
        • Hays M.T.
        Absorption of oral thyroxine in man.
        J Clin Endocr. 1968; 28: 749-756
        • Read D.G.
        • Hays M.T.
        • Hershman J.M.
        Absorption of oral thyroxine in hypothyroid and normal man.
        J Clin Endocr. 1970; 30: 798-799
        • Ward L.S.
        The difficult patient: drug interaction and the influence of concomitant diseases on the treatment of hypothyroidism.
        Arq Bras Endocrinol Metab. 2010; 54: 435-442
        • Jiskra J.
        • Limanova Z.
        • Vanickova Z.
        • Kocna P.
        IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy.
        Physiol Res. 2003; 52: 79-88
        • d'Esteve-Bonetti L.
        • Bennet A.P.
        • Malet D.
        • et al.
        Gluten-induced enteropathy (coeliac disease) revealed by resistance to treatment with levothyroxine and alfacalcidol in a sixty-eight-year old patient: a case report.
        Thyroid. 2002; 12: 633-636
        • McDermott J.H.
        • Coss A.
        • Walsh C.H.
        Celiac disease presenting as resistant hypothyroidism.
        Thyroid. 2005; 15: 386-388
        • Chamberland D.
        • Weight C.
        • Rasmussen M.
        • et al.
        Thyroxine malabsorption in a patient with type 1 diabetes and celiac disease.
        Endocr Pract. 2005; 11: 203-204
        • Caputo M.
        • Brizzolara R.
        • Schiavo M.
        • et al.
        Occurrence of overt celiac disease in the elderly following total thyroidectomy.
        J Endocrinol Invest. 2006; 29: 831-833
        • Davenport H.W.
        Physiology of the Digestive Tract.
        4th ed. Year Book Medical Publishers Inc., Chicago1977